Analysts expect C4 Therapeutics, Inc. to report revenue of 8.34 M for Q3 26, against a range of 7.82 M to 8.86 M. The most recent reported quarter, Q2 26, came in at 6.64 M, a 56.6% beat against the 4.24 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 15.40 M | 5.18 M | 7.20 M | 6.46 M | 11.20 M | 11.02 M | 6.20 M | 6.64 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 6.08 M | 5.05 M | 4.94 M | 7.21 M | 6.71 M | 6.10 M | 5.13 M | 4.38 M | 8.86 M | 4.09 M | 5.55 M | 5.63 M | 8.17 M | 4.01 M | 4.04 M | 4.65 M | ||||||||||
| Low Estimate | 5.46 M | 4.53 M | 4.27 M | 6.71 M | 6.21 M | 5.35 M | 4.21 M | 4.10 M | 7.82 M | 3.46 M | 5.01 M | 4.79 M | 6.86 M | 3.59 M | 3.62 M | 4.12 M | ||||||||||
| Consensus Estimate | 5.77 M | 4.79 M | 4.60 M | 6.96 M | 6.46 M | 5.73 M | 4.67 M | 4.24 M | 8.34 M | 3.77 M | 5.28 M | 5.21 M | 7.52 M | 3.80 M | 3.83 M | 4.38 M |
Analysts expect C4 Therapeutics, Inc. to report earnings per share of -0.21 for Q3 26, against a range of -0.22 to -0.20. The most recent reported quarter, Q2 26, came in at -0.18, a 28.0% beat against the -0.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.35 | -0.49 | -0.37 | -0.37 | -0.44 | -0.18 | -0.20 | -0.18 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.38 | -0.43 | -0.40 | -0.38 | -0.38 | -0.29 | -0.25 | -0.24 | -0.20 | -0.29 | -0.27 | -0.20 | -0.20 | -0.22 | -0.29 | -0.28 | ||||||||||
| Low Estimate | -0.40 | -0.51 | -0.42 | -0.42 | -0.46 | -0.33 | -0.29 | -0.26 | -0.22 | -0.31 | -0.29 | -0.24 | -0.22 | -0.26 | -0.31 | -0.30 | ||||||||||
| Consensus Estimate | -0.39 | -0.47 | -0.41 | -0.40 | -0.42 | -0.31 | -0.27 | -0.25 | -0.21 | -0.30 | -0.28 | -0.22 | -0.21 | -0.24 | -0.30 | -0.29 |
Pull Wall Street consensus for C4 Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CCCC&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CCCC", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CCCC&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();